Empowering trial staff one course at a time
Related posts: c4c submits a shared response to the FDA consultation c4c’s 1st publication IMI publishes articles about c4c progess National Hub meeting outcomes
Detailsc4c providing strategic feasibility advice
Related posts: c4c submits a shared response to the FDA consultation c4c’s 1st publication IMI publishes articles about c4c progess National Hub meeting outcomes
Details
We did it – first c4c online Train the Trainers Workshop held!
We did it – first c4c online Train the Trainers Workshop held! The c4c Patient and Public Involvement (PPI) Team work to ensure that the voice and opinion of children, young people and families is embedded throughout the c4c project. On 16 – 17 September 2020, the first virtual “Train the Trainers” workshop was held…
Detailsc4c’s 1st publication
conect4children (c4c) is pleased to announce its first publication. The review titled “European research networks to facilitate drug research in children” has been published by the British Journal of Clinical Pharmacology. This review discusses the need for a structured approach to drug development by establishing and utilizing research networks and infrastructures. The publication…
Details
c4c submits a shared response to the FDA consultation
On behalf of European Rare Disease community, c4c submits a shared response to the FDA consultation about a global clinical trials network in rare diseases. On May 29th this year, the FDA opened a consultation to obtain information and comments from patients, patient advocates, the scientific community, health professionals, other regulatory and health authorities in the…
Details